ArticleBlood advances2021
Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification.
Inge van der Werf et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this papercites it